What are Mission Vision & Core Values of Bristol Myers Squibb Company?

What drives Bristol Myers Squibb today?

Bristol Myers Squibb focuses on delivering transformative medicines in oncology, immunology, hematology and cardiovascular disease while investing heavily in R&D to sustain long-term innovation and patient impact.

These guiding statements align capital allocation, M&A and portfolio choices to prioritize scientific excellence, patient outcomes and sustainable growth.

What are Mission Vision & Core Values of Bristol Myers Squibb Company? Explore how purpose, ambition and values shape strategic decisions and resilience, and see related analysis at Bristol Myers Squibb Porter's Five Forces Analysis.

Bristol Myers Squibb’s mission centers on patients, innovation and global delivery of high‑value medicines, driving research‑intensive therapies to address unmet serious disease needs.

Patient‑centric focus

The mission targets patients with life‑threatening conditions, prioritizing outcomes that help them prevail.

Innovation-led R&D

Emphasis on first‑in‑class, research‑intensive medicines rather than generics, fueling therapeutic breakthroughs.

Global market reach

Operations and distribution span continents to serve diverse patient populations worldwide.

Strategic acquisitions

The $14 billion 2023‑24 acquisition of Karuna expanded neuroscience capabilities aligned with the mission.

Clinical leadership in oncology

Continued development of Opdivo plus Yervoy combinations has reshaped treatment standards and outcomes.

Financial scale

The mission underpins a commercial engine generating about $47 billion in annual revenue (2024 figures).

The mission is innovation‑focused and patient‑centric, reflected in strategic deals and therapies that drive BMS company purpose and core values.

Mission: To discover, develop and deliver innovative medicines that help patients prevail over serious diseases — this guides Bristol Myers Squibb mission, BMS vision statement and Bristol Myers Squibb core values; see Mission, Vision & Core Values of Bristol Myers Squibb for more details.

Complete Bristol Myers Squibb Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

BMS vision statement focuses on global leadership through science-driven patient impact, leveraging advanced modalities to transform care while offsetting legacy patent cliffs.

Scientific Leadership

The vision centers on pioneering science—protein degradation, cell therapy and radiopharmaceuticals—to redefine treatments.

Pipeline Depth

As of 2025, BMS advances over 50 clinical-stage compounds supporting the Bristol Myers Squibb mission.

Strategic Acquisitions

The $4.1B RayzeBio acquisition expands radiopharmaceutical diagnostics and therapeutics capabilities.

Commercial Transition

BMS is reshaping its portfolio to mitigate patent expiries on products like Revlimid and Eliquis while pursuing growth.

Patient-Centric Purpose

The BMS company purpose emphasizes transforming patients’ lives—core to Bristol Myers Squibb values and mission.

Measurable Progress

Financially, 2024 revenues reflected continued reinvestment into R&D to sustain the vision and core values.

The vision is ambitious yet actionable: lead globally through high-science innovation, supported by a robust pipeline and targeted M&A—see Competitors Landscape of Bristol Myers Squibb for context.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Bristol Myers Squibb core values guide its decisions and culture, shaping how the company advances patient-focused innovation and conducts business globally. These values underpin the BMS vision statement and inform the Bristol Myers Squibb mission across R&D, operations and partnerships.

Integrity

BMS upholds the highest ethical standards, ensuring transparency in clinical data and rigorous safety protocols to build trust with patients and providers.

Innovation

The company invests heavily in early-stage research and novel modalities to drive scientific breakthroughs and expand therapeutic options.

Urgency & Accountability

BMS acts with urgency to accelerate development timelines while holding teams accountable through performance metrics tied to R&D milestones and commercial targets.

Inclusion & Passion

The company promotes diversity in its workforce and clinical trials and sustains a passionate focus on patient outcomes, tackling hard-to-treat diseases.

Explore how the Bristol Myers Squibb mission and BMS vision statement shape strategy, investments and portfolio choices next — read on to see their impact on R&D prioritization and commercial planning.

Values
Bristol Myers Squibb operates under six core values that define its corporate culture and business practices.
Integrity: This value dictates that the company conducts business with the highest ethical standards. In practice, this manifests in the transparency of clinical trial data and a commitment to rigorous safety protocols, ensuring that healthcare providers and patients can trust the efficacy of BMS products.
Innovation: As the lifeblood of the company, innovation is seen in the constant pursuit of scientific breakthroughs. It is evidenced by the company’s willingness to invest heavily in risky, early-stage research that has the potential to create entirely new classes of medicine.
Urgency: This value reflects the understanding that for patients with serious diseases, every day counts. BMS applies urgency to its drug development timelines and regulatory submission processes, striving to bring life-saving treatments to market as quickly as possible without compromising safety.
Accountability: Employees and leadership are held responsible for delivering on commitments. This value is integrated into the company’s performance metrics, which track progress against R&D milestones and financial targets, such as the goal of generating $10,000,000,000 in new product sales by 2026.
Inclusion: BMS promotes a diverse workforce and inclusive environment. This manifests in the company’s global inclusion and diversity goals, which include increasing the representation of underrepresented groups in clinical trials to ensure that medicines are effective across all demographics.
Passion: The company fosters a culture of dedication to the patient cause. This passion is visible in the long-term commitment of its scientific teams to tackle some of the most difficult challenges in medicine, such as treatment-resistant cancers. These values collectively differentiate BMS from competitors by fostering a culture that balances high-performance expectations with a deep sense of social responsibility.
Revenue Streams & Business Model of Bristol Myers Squibb

Bristol Myers Squibb Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Mission and vision guide Bristol Myers Squibb’s strategic choices, shaping R&D priorities, M&A and market expansion. These statements ensure decisions advance the company’s aim to deliver innovative medicines to patients worldwide.

Mission, Vision & Core Values — Snapshot

Bristol Myers Squibb mission centers on discovering, developing and delivering transformational medicines; the BMS vision statement emphasizes science-driven innovation for patients.

• The mission prioritizes patient impact and scientific excellence
• The vision focuses on long-term, science-led leadership in specialty care
• Core values include integrity, innovation, urgency and collaboration
• Strategy metrics tie R&D choices to measurable patient outcomes

R&D Focus

The mission directs investment to oncology, immunology and cardiovascular research where patient need and scientific opportunity align.

Mergers & Acquisitions

Acquisitions are evaluated for their ability to strengthen the pipeline; the $5.8 billion acquisition of Mirati (2024–2025 period data) targeted oncology precision medicines.

Market Prioritization

Geographic expansion prioritizes regions with high disease burden and infrastructure to deliver complex biologics.

Performance Metrics

Between 2021 and 2025, BMS launched nine new products, linking mission to operational outcomes.

Leadership Messaging

CEO statements reinforce that science-led focus and high-value medicines drive sustainable growth and shareholder value.

Day-to-Day Operations

Project selection favors programs with greatest potential patient impact, ensuring R&D portfolio aligns with Bristol Myers Squibb core values and mission.

Explore how these mission and vision priorities shape strategic choices and read next: Core Improvements to Company's Mission and Vision. Owners & Shareholders of Bristol Myers Squibb

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE

Four focused improvements can modernize the company mission and vision to reflect digital innovation, global access, measurable impact, and stakeholder alignment. Each improvement below targets clarity, strategic relevance, and alignment with 2025 industry trends.

Embed digital innovation into the mission

Update the Bristol Myers Squibb mission to reference AI and data-driven R&D, e.g., 'transforming lives through science and digital innovation', aligning BMS vision statement with the 2025 shift where data science complements lab science and AI reduces drug development timelines by up to 30% in pilot programs.

Prioritize global health equity and affordability

Incorporate explicit commitments to drug affordability and access into the mission to reflect growing global demand and position Bristol Myers Squibb core values around equitable distribution, supporting measurable targets for low- and middle-income countries.

Set measurable impact metrics

Include specific KPIs (patient reach, affordability indices, R&D success-rate improvements) in the BMS company purpose so progress on the vision is transparent; for example, commit to increasing global patient access by 20% over five years.

Align stakeholder and employee-facing values

Refine Bristol Myers Squibb values and mission to explicitly address employee purpose, partner collaboration, and ESG integration, strengthening culture metrics tied to retention and innovation output.

Improvements While the current mission and vision statements are robust, they could be strengthened by incorporating the role of digital technology and artificial intelligence in modern drug discovery. As of 2025, the industry is moving toward a model where data science is as critical as laboratory science. A refinement such as 'transforming lives through science and digital innovation' would better reflect the company's increasing reliance on AI-driven R&D platforms. This adjustment would align BMS with the industry trend of integrating technology to reduce drug development costs and improve success rates.

Additionally, the statements could more explicitly address the growing global demand for health equity and drug affordability. While these are addressed in corporate social responsibility reports, bringing them into the mission statement would signal a stronger commitment to ensuring that innovative medicines are accessible to broader populations, not just those in high-income markets. Framing these suggestions as growth opportunities, BMS could lead the industry by defining 'leadership' not just by scientific output or revenue, but by the global accessibility of its life-saving innovations.

Related resource: Target Market of Bristol Myers Squibb